(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.14%) $0.800
(-0.07%) $92.11
1.35% INR 1 615.95
Live Chart Being Loaded With Signals
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs)...
Stats | |
---|---|
Tagesvolumen | 587 179 |
Durchschnittsvolumen | 1.20M |
Marktkapitalisierung | 736.47B |
EPS | INR0 ( 2024-02-06 ) |
Nächstes Ertragsdatum | ( INR11.24 ) 2024-05-06 |
Last Dividend | INR4.00 ( 2023-07-14 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 41.32 |
ATR14 | INR0.956 (0.06%) |
Volumen Korrelation
Lupin Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Lupin Limited Korrelation - Währung/Rohstoff
Lupin Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR162.70B |
Bruttogewinn: | INR94.90B (58.33 %) |
EPS: | INR9.46 |
FY | 2022 |
Umsatz: | INR162.70B |
Bruttogewinn: | INR94.90B (58.33 %) |
EPS: | INR9.46 |
FY | 2022 |
Umsatz: | INR161.93B |
Bruttogewinn: | INR91.05B (56.23 %) |
EPS: | INR-33.24 |
FY | 2021 |
Umsatz: | INR149.29B |
Bruttogewinn: | INR95.67B (64.08 %) |
EPS: | INR26.84 |
Financial Reports:
No articles found.
Lupin Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR4.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR4.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.250 | 2002-01-24 |
Last Dividend | INR4.00 | 2023-07-14 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | INR80.35 | -- |
Avg. Dividend % Per Year | 0.37% | -- |
Score | 2.12 | -- |
Div. Sustainability Score | 4.31 | |
Div.Growth Potential Score | 3.91 | |
Div. Directional Score | 4.11 | -- |
Year | Amount | Yield |
---|---|---|
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR5.00 | 0.65% |
2019 | INR5.00 | 0.59% |
2020 | INR6.00 | 0.78% |
2021 | INR6.50 | 0.65% |
2022 | INR4.00 | 0.42% |
2023 | INR4.00 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
APOLSINHOT.NS | Dividend Junior | 2023-09-22 | Annually | 10 | 0.11% | |
TDPOWERSYS.NS | Dividend Junior | 2023-08-02 | Annually | 13 | 0.31% | |
OLECTRA.NS | Dividend Junior | 2023-09-21 | Sporadic | 23 | 0.03% | |
INTENTECH.NS | Dividend Junior | 2023-09-21 | Annually | 6 | 0.44% | |
COROMANDEL.NS | Dividend Knight | 2023-07-13 | Annually | 19 | 1.02% | |
SHALBY.NS | Dividend Junior | 2023-08-08 | Annually | 6 | 0.51% | |
MANALIPETC.NS | Dividend Junior | 2023-09-15 | Annually | 18 | 1.50% | |
GPPL.NS | Dividend Knight | 2023-07-26 | Semi-Annually | 9 | 2.89% | |
AXISBANK.NS | Dividend Junior | 2023-07-06 | Sporadic | 26 | 0.06% | |
TRU.NS | Dividend Junior | 2023-09-18 | Annually | 3 | 0.01% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0938 | 1.500 | 8.12 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.139 | 1.500 | 9.57 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 7.49 | 1.000 | 8.34 | 8.34 | [3 - 30] |
operatingCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.643 | 1.000 | 2.62 | 2.62 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.131 | 1.000 | 9.39 | 9.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.31 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 41.08 | 1.000 | 5.95 | 0 | [1 - 100] |
returnOnEquityTTM | 0.139 | 2.50 | 9.72 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.248 | 1.500 | 3.81 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.291 | 1.500 | -1.393 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0806 | 1.000 | -0.486 | 0 | [0.1 - 0.5] |
Total Score | 3.91 |
Lupin Limited
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.